{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/briefcynata-advances-toward-phase-2-clinical-trial-of-cymerustm-mscs-in-patients-with-osteoarthritis-1968413", "downloaded_at": "2019-10-04 12:49:50.496138+00:00", "title": "BRIEF-Cynata Advances Toward Phase 2 Clinical Trial Of Cymerus(Tm) MSCs In Patients With Osteoarthritis", "language": "en", "text": "BRIEF-Cynata Advances Toward Phase 2 Clinical Trial Of Cymerus(Tm) MSCs In Patients With Osteoarthritis\n\nStock Markets 29 minutes ago (Oct 04, 2019 22:20)\n\n\u00a9 Reuters. BRIEF-Cynata Advances Toward Phase 2 Clinical Trial Of Cymerus(Tm) MSCs In Patients With Osteoarthritis Oct 4 (Reuters) - Cynata Therapeutics Ltd : * CYNATA ADVANCES TOWARD PHASE 2 CLINICAL TRIAL OF CYMERUS(TM) MSCS IN PATIENTS WITH OSTEOARTHRITIS * CYNATA THERAPEUTICS LTD - PHASE 2 CLINICAL TRIAL IN OSTEOARTHRITIS EXPECTED TO COMMENCE IN QUARTER 1 2020\n\nBRIEF-Cynata Advances Toward Phase 2 Clinical Trial Of Cymerus(Tm) MSCs In Patients With Osteoarthritis", "description": "BRIEF-Cynata Advances Toward Phase 2 Clinical Trial Of Cymerus(Tm) MSCs In Patients With Osteoarthritis", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEB280W7_L.jpg", "published_at": "2019-10-04"}